Tissue oxygen saturation predicts response to breast cancer neoadjuvant chemotherapy within 10 days of treatment

Ideally, neoadjuvant chemotherapy (NAC) assessment should predict pathologic complete response (pCR), a surrogate clinical endpoint for 5-year survival, as early as possible during typical 3- to 6-month breast cancer treatments. We introduce and demonstrate an approach for predicting pCR within 10 d...

Descripción completa

Detalles Bibliográficos
Autores principales: Cochran, Jeffrey M., Busch, David R., Leproux, Anaïs, Zhang, Zheng, O’Sullivan, Thomas D., Cerussi, Albert E., Carpenter, Philip M., Mehta, Rita S., Roblyer, Darren, Yang, Wei, Paulsen, Keith D., Pogue, Brian, Jiang, Shudong, Kaufman, Peter A., Chung, So Hyun, Schnall, Mitchell, Snyder, Bradley S., Hylton, Nola, Carp, Stefan A., Isakoff, Steven J., Mankoff, David, Tromberg, Bruce J., Yodh, Arjun G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society of Photo-Optical Instrumentation Engineers 2018
Materias:
Special Section on Translational Biophotonics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194199/
https://www.ncbi.nlm.nih.gov/pubmed/30338678
http://dx.doi.org/10.1117/1.JBO.24.2.021202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6194199/
https://www.ncbi.nlm.nih.gov/pubmed/30338678
http://dx.doi.org/10.1117/1.JBO.24.2.021202

Ejemplares similares